Navigation Links
ASCO and ASH Release Updated Guideline on the Use of Chemotherapy-Related Anemia Treatments in Cancer Patients
Date:10/22/2007

g). The guideline will be published in print in both journals on December 1.

The American Society of Hematology (http://www.hematology.org) is the world's largest professional society concerned with the causes and treatment of blood disorders. Its mission is to further the understanding, diagnosis, treatment, and prevention of disorders affecting blood, bone marrow, and the immunologic, hemostatic, and vascular systems, by promoting research, clinical care, education, training, and advocacy in hematology. Blood, the official journal of the American Society of Hematology, is the most cited peer-reviewed publication in the field. Blood is issued to Society members and other subscribers twice per month, available in print and online at http://www.bloodjournal.org.

The American Society of Clinical Oncology (ASCO) is the world's leading professional organization representing physicians of all oncology subspecialties who care for people with cancer. ASCO's nearly 25,000 members from the United States and abroad set the standard for patient care and lead the efforts to discover more effective cancer treatments, increase funding for clinical and translational research, and, ultimately, improve cancer care for the estimated 10 million people diagnosed with cancer worldwide each year. ASCO publishes the Journal of Clinical Oncology (JCO), the preeminent, peer-reviewed, medical journal on clinical cancer research, and produces People Living With Cancer (http://www.PLWC.org), a comprehensive consumer Web site providing oncologist-vetted cancer information to help patients and families make informed health-care decisions.


'/>"/>
SOURCE American Society of Hematology
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Halozyme Therapeutics Enhanze Technology Large Protein Molecule Therapeutic Clinical Trial Results Presented at the 34th Annual Meeting of the Controlled Release Society
2. Mayo Clinic News Release: Mayo Clinic-led Study Improves Breast Cancer Risk Prediction in Women with Atypia
3. Lupus Foundation of America Statement on Results for Clinical Study of CellCept Released by Aspreva Pharmaceutical Company
4. An Investigational Study Released at ADA Showed that Initial Combination Therapy with Januvia (sitagliptin) and Metformin Led to Improvement in Markers of Beta Cell Function in Patients with Type 2 Diabetes
5. Phase IIIb Clinical Data Validate the Overall and Cardiovascular Safety Profile of Cycloset (A Quick Release Formulation of Bromocriptine Mesylate) in Patients with Type 2 Diabetes
6. Late Breaking Data Released at ADA Showed that the Investigational Use of Januvia and Metformin as Initial Combination Therapy Provided Significant Glucose Lowering Efficacy over 54 Weeks in Patients with Type 2 Diabetes
7. VeroScience Late-Breaking Abstract on Cycloset (A Quick Release Formulation of Bromocriptine Mesylate) Accepted for Poster Presentation at American Diabetes Association 67th Scientific Sessions
8. Critical Therapeutics Announces the Publication of Data for ZyfloCR (Zileuton) Extended-Release Tablets in the Journal of Asthma
9. OREXIGEN Therapeutics Announces Sustained-Release Formulation of Zonisamide Shows Improved Tolerability When Compared to Immediate Release Formulation
10. New Research Confirms the Benefit of Extended-Release Dipyridamole Plus ASA for Preventing Recurrent Stroke in Low- and High-Risk Patients
11. Shire Announces Positive Results of Studies With Guanfacine Extended Release, An Investigational Nonstimulant Medication Filed for the Treatment of ADHD in Children and Adolescents

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/30/2009)...v. 30 Reportlinker.com announces t...ts catalogue: ,, Decubitus Ulcer Treatment Pro...ww.reportlinker.com/p0164283/Decubitus-Ulcer-Treat..., Decubitus Ulcers are lesions resulting from t...tient,s bodyweight. Pressure ulcer treatment produ...
(Date:11/30/2009)...v. 30 The Simmons law firm,s Trent...presenting thousands of women that were seriously ...th control pill manufactured and marketed by Bayer... Multidistrict Litigation has ordered that all fed... consolidated and centralized for pretrial litigat...
(Date:11/30/2009)...0 Minimally-invasive procedures ar... particularly in oncology, cardiology and women,s ...ge-guided navigation expected to reach $600 millio... offered by minimally-invasive procedures, includi... comfort and faster patient throughput. ,, (L...
Breaking Medicine Technology:Reportlinker Adds Decubitus Ulcer Treatment Products - A Worldwide Market Review 2Reportlinker Adds Decubitus Ulcer Treatment Products - A Worldwide Market Review 3Reportlinker Adds Decubitus Ulcer Treatment Products - A Worldwide Market Review 4Reportlinker Adds Decubitus Ulcer Treatment Products - A Worldwide Market Review 5Reportlinker Adds Decubitus Ulcer Treatment Products - A Worldwide Market Review 6Simmons Firm's Partner Trent Miracle Chosen to Help Lead National Litigation Against Bayer 2Philips Showcases Interventional Radiology Solutions to Support Growing Need For Minimally-Invasive Procedures 2Philips Showcases Interventional Radiology Solutions to Support Growing Need For Minimally-Invasive Procedures 3Philips Showcases Interventional Radiology Solutions to Support Growing Need For Minimally-Invasive Procedures 4Philips Showcases Interventional Radiology Solutions to Support Growing Need For Minimally-Invasive Procedures 5Backyard Raccoon Latrines Harbor Hidden Dangers 54549 1Backyard Raccoon Latrines Harbor Hidden Dangers 54549 2Backyard Raccoon Latrines Harbor Hidden Dangers 54549 3UOG scientists successfully compete for research grants 9577 1UOG scientists successfully compete for research grants 9577 2New strategy for inhibiting virus replication 9572 1New strategy for inhibiting virus replication 9572 2
(Date:11/30/2009)...13 chest X-rays, study finds , , MONDAY,...ients who have abdominal/pelvic CT scans receive a...em to extra radiation, U.S. researchers say. , ...ere performed on 500 patients aged 9 months to 91 ... age. The researchers concluded that 35.3 percent ...
(Date:11/30/2009)... in child deaths linked to flu, , , MON...cials said Monday that H1N1 swine flu infections a...mber of American children dying from the illness c... Monday by the U.S. Centers for Disease Control an...for influenza-like illness nationally decreased sh...
(Date:11/30/2009)...SNewswire/ -- SEIU Local 21LA members and New Orle...l hold a rally Tuesday, Dec. 1, 2009, at noon at S...0 Desire Parkway, New Orleans, to protest an unrea...licies that target employees who are ill or who ne...ees who clean schools in the Recovery School Distr...
(Date:11/30/2009)...swire-FirstCall/ -- Jedi Mind, Inc . (Pink Sheets...ce the Company,s first thought-controlled game is ...ink-Tac-Toe" is the first of its kind, which allow...r mind and is geared towards people of all ages. T...can be purchased directly through the Company by c...
(Date:11/30/2009)...nt To Simulate High Altitude, Low O2 Conditions ...- Distance runners who live at high altitudes with...ormance during races in areas that are at sea leve...atigue, improve their exercise performance by stay... That is the question being studied among 15 heart...
Breaking Medicine News(10 mins):Health News:CT Scan Patients May Get Unnecessary Imaging 2Health News:U.S. Swine Flu Cases Chart Sharp Decline 2Health News:U.S. Swine Flu Cases Chart Sharp Decline 3Health News:As H1NI Hits New Orleans in Force: School Custodians to Hold Rally to Call on Contractor to Stop Penalizing Workers Coping With Illness 2Health News:First Thought-Controlled Game Complete From Jedi Mind, Inc. 2Health News:Can Exposure to Low Oxygen Levels Benefit Heart Failure Patients? 2Health News:Can Exposure to Low Oxygen Levels Benefit Heart Failure Patients? 3Health News:Can Exposure to Low Oxygen Levels Benefit Heart Failure Patients? 4
... Management Health Solutions, Inc. (MHS),...gement solutions to the health care industry, anno...ting Group, a firm specializing in medical supply ...ch 26, 2009-- Management Health Solutions, Inc. (...
... March 26 Michigan State Board of Education Presi...ional Federation of the Blind of Michigan to launc... at 10:30 am in the Rotunda of the Michigan State... Michigan is joining in a nationwide campaign to d...
...h 25 Anadys Pharmaceuticals, Inc. (Nasdaq: ANDS...4th Annual Biotech Day on Wednesday, April 1, 2009...e will be held at the 388 Greenwich Street Confere...pdate on its ANA598 clinical program in hepatitis ...
...., March 25 Endo Pharmaceuticals Solutions Inc. (...oday commenced an offer to purchase any or all of ... 2009 in accordance with the indenture governing t....m., Eastern time, on April 22, 2009. , , In the ...
... Service Helps Manage Insurance Plan Authorization...., March 25 Recondo Technology, a leading provide...dustry, today announced the release schedule of Au...5 percent of all payer-denied claims, and can resu...
...March 25 The Texas Medical Association (TMA) join...day that would make using health insurance better ...lem: Too often patients do not understand their he...," said Josie R. Williams, M.D., TMA,s president. ...
Other Medicine News:Health News:Management Health Solutions, Inc. Selects NCI Consulting Group as Dedicated Representative to IDN's and GPO's 2Health News:Kathleen Strauss to Help Launch Braille Literacy Campaign 2Health News:Anadys Pharmaceuticals to Present at the Citi Biotech Day 2Health News:Endo Pharmaceuticals Solutions (Formerly Indevus Pharmaceuticals, Inc.) Announces Commencement of Offer to Purchase Its 6.25% Convertible Senior Notes Due 2009 2Health News:Endo Pharmaceuticals Solutions (Formerly Indevus Pharmaceuticals, Inc.) Announces Commencement of Offer to Purchase Its 6.25% Convertible Senior Notes Due 2009 3Health News:Recondo Technology Announces Authorization and Denial Prevention Software Service 2Health News:TMA Physicians and Legislators: 'Patients Have a Right to Know' 2Health News:TMA Physicians and Legislators: 'Patients Have a Right to Know' 3
Replacement Burr/Chuck
Diamond Burr - Disk
Muldoon Lacrimal Dilator
Wilder Lacrimal Dilator - Medium
Medicine Products: